Charles F. Thomas
- Epidemiology top 2%
- Pneumocystis jirovecii pneumonia detection and treatment 24
- Neuroendocrine Tumor Research Advances 6
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility 8
- HIV/AIDS drug development and treatment 7
- Tuberculosis Research and Epidemiology 6
- Microbiology top 5%
- Oncology top 5%
- Peptidase Inhibition and Analysis 9
- Lung Cancer Research Studies 6
-
- Synthesis and Biological Evaluation 8
Charles F. Thomas
61 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Epidemiology 1.5k
- Infectious Diseases 822
- Microbiology 24
- Pulmonary and Respiratory Medicine 802
- Oncology 600
Countries citing papers authored by Charles F. Thomas
This map shows the geographic impact of Charles F. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles F. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles F. Thomas more than expected).
Fields of papers citing papers by Charles F. Thomas
This network shows the impact of papers produced by Charles F. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles F. Thomas. The network helps show where Charles F. Thomas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles F. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2018 | 50 | |
| 3 | The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancerbreakdown → | 2015 | 530 |
| 4 | 2014 | 7 | |
| 5 | 2011 | 5 | |
| 6 | 2008 | 28 | |
| 7 | 2007 | 72 | |
| 8 | 2004 | 20 | |
| 9 | Pneumocystis Pneumoniabreakdown → | 2004 | 708 |
| 10 | 2003 | 2 | |
| 11 | 2003 | 0 | |
| 12 | 2002 | 98 | |
| 13 | 2001 | 3 | |
| 14 | 2001 | 21 | |
| 15 | 2000 | 2 | |
| 16 | 1998 | 28 | |
| 17 | 1997 | 36 | |
| 18 | 1997 | 4 | |
| 19 | 1996 | 5 | |
| 20 | Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement. | 1995 | 5 |
About Charles F. Thomas
Charles F. Thomas is a scholar working on Infectious Diseases, Epidemiology and Conservation, having authored 64 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (24 papers), Peptidase Inhibition and Analysis (9 papers), Synthesis and Biological Evaluation (8 papers), Antifungal resistance and susceptibility (8 papers), HIV/AIDS drug development and treatment (7 papers), Tuberculosis Research and Epidemiology (6 papers), Neuroendocrine Tumor Research Advances (6 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Epidemiology (1.5k citations), Infectious Diseases (822 citations) and Microbiology (24 citations). Charles F. Thomas has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Andrew H. Limper, James R. Jett, Robert Vassallo, Ramón Rami–Porta, Vanessa Bolejack, Kenji Suzuki, David Ball, Thomas W. Rice, William D. Travis and Gustavo Lyons. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.